Study guide
Acute asthma and COPD exacerbations
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Acute asthma and COPD exacerbations
Key Takeaways Explain This Topic AI
Adult acute-asthma emergency care targets oxygen saturation of 92–96%.
COPD patients at risk of hypercapnia generally need controlled oxygen targeting 88–92%.
A silent chest, exhaustion or altered consciousness signals a life-threatening asthma attack.
Last updated: October 2026
Acute Severe Asthma: Emergency Management
Acute severe asthma is an immediate medical emergency. Severity classification dictates the aggressiveness of pharmacological escalation and monitoring.
Severity Stratification in Acute Asthma
Mild to Moderate: Speaks in phrases, heart rate 100 − 120 bpm 100-120\text{ bpm} 100 − 120 bpm , respiratory rate < 25 breaths/min < 25\text{ breaths/min} < 25 breaths/min , oxygen saturation ≥ 94 % \ge 94\% ≥ 94% , PEF 50 − 75 % 50-75\% 50 − 75% predicted.
Severe: Cannot complete sentences in one breath, accessory muscle use, respiratory rate > 25 breaths/min > 25\text{ breaths/min} > 25 breaths/min , heart rate > 110 bpm > 110\text{ bpm} > 110 bpm , oxygen saturation < 93 % < 93\% < 93% , PEF 33 − 50 % 33-50\% 33 − 50% predicted.
Life-Threatening: Silent chest on auscultation, cyanosis, feeble respiratory effort, bradycardia or dysrhythmia, hypotension, exhaustion, altered conscious state, PEF < 33 % < 33\% < 33% predicted, or a normal/elevated arterial PaCO 2 \text{PaCO}_2 PaCO 2 ( > 42 mmHg > 42\text{ mmHg} > 42 mmHg ). In a hyperventilating patient, a 'normal' PaCO 2 \text{PaCO}_2 PaCO 2 signals respiratory muscle fatigue and impending respiratory arrest.
Emergency Pharmacological Protocol
Acute adult asthma oxygen: Give oxygen if SpO2 is below 92% and titrate to 92–96%. Patients at risk of hypercapnic respiratory failure need a target such as 88–92% and blood-gas monitoring. Uncontrolled high oxygen concentrations are not universally harmless.
Inhaled Bronchodilators: Administer salbutamol ( 5 mg 5\text{ mg} 5 mg ) plus ipratropium bromide ( 500 μ g 500\ \mu\text{g} 500 μ g ) nebulised back-to-back using oxygen at 6 − 8 L/min 6-8\text{ L/min} 6 − 8 L/min , or salbutamol 12 puffs via a pressurized metered-dose inhaler (pMDI) with a large-volume spacer (giving 1 puff per 4 tidal breaths) every 15 to 20 minutes for the first hour.
Systemic Corticosteroids: Initiate oral prednisolone 50 mg 50\text{ mg} 50 mg immediately. If the patient is vomiting, unable to swallow, or in extremis, administer intravenous hydrocortisone 100 mg 100\text{ mg} 100 mg every 6 hours. Systemic steroids accelerate resolution of airway mucosal oedema and reduce relapse rates.
Intravenous Magnesium Sulfate: For patients presenting with severe or life-threatening features refractory to initial bronchodilator therapy, infuse intravenous magnesium sulfate 2 g 2\text{ g} 2 g ( 8.4 mmol 8.4\text{ mmol} 8.4 mmol ) in 100 mL 100\text{ mL} 100 mL normal saline over 20 minutes. Magnesium induces bronchial smooth muscle relaxation through calcium channel antagonism.
Intravenous Salbutamol and Aminophylline: Reserved strictly for intensive care settings under continuous invasive hemodynamic monitoring when intubation is imminent. Intravenous salbutamol carries significant risks of severe lactic acidosis, hypokalaemia, and tachyarrhythmias.
Acute Exacerbation of COPD (AECOPD)
An acute exacerbation of COPD is an acute worsening of baseline respiratory symptoms (dyspnoea, cough, sputum volume, and sputum purulence) beyond normal day-to-day variations that warrants a change in regular medication.
Controlled Oxygen Delivery
Excess oxygen can worsen CO2 retention in COPD, largely through V/Q changes and the Haldane effect, with altered ventilation also contributing. It is not simply loss of a hypoxic drive. Titrate to the prescribed target and obtain blood gases when indicated; acute asthma can also develop ventilatory failure and should not receive indiscriminate oxygen.
Delivery System: Use 24% or 28% Venturi masks or low-flow nasal cannulae at 1 − 2 L/min 1-2\text{ L/min} 1 − 2 L/min . Monitor arterial blood gases (ABG) at baseline and repeat within 30 to 60 minutes after initiating or adjusting oxygen therapy.
Pharmacological Escalation
Bronchodilators: Nebulised salbutamol ( 2.5 − 5 mg 2.5-5\text{ mg} 2.5 − 5 mg ) and ipratropium bromide ( 500 μ g 500\ \mu\text{g} 500 μ g ) driven by compressed air (never unmonitored oxygen; if oxygen is required, bleed low-flow oxygen via nasal prongs at 2 L/min 2\text{ L/min} 2 L/min beneath the air-driven nebuliser mask).
Systemic Corticosteroids: Oral prednisolone 30 − 50 mg 30-50\text{ mg} 30 − 50 mg once daily for 5 days . Extended courses offer no additional benefit and increase risks of hyperglycemia, secondary infection, and prolonged hospital stays.
Antimicrobial Therapy: Prescribed based on the Anthonisen criteria when patients exhibit increased sputum purulence plus either increased sputum volume or increased dyspnoea. First-line oral therapy per Australian Therapeutic Guidelines is amoxicillin 500 mg 500\text{ mg} 500 mg every 8 hours or doxycycline 100 mg 100\text{ mg} 100 mg every 12 hours for 5 days.
Non-Invasive Ventilation (NIV / BiPAP)
Non-invasive bilevel positive airway pressure ventilation is the standard of care for acute hypercapnic respiratory failure complicating AECOPD. NIV reduces work of breathing, improves alveolar ventilation, lowers intubation rates by over 60%, and significantly reduces inpatient mortality.
Arterial Blood Gas : Criteria for Initiating NIV in AECOPD: Persistent respiratory acidosis ( pH < 7.35 \text{pH} < 7.35 pH < 7.35 and PaCO 2 > 45 mmHg \text{PaCO}_2 > 45\text{ mmHg} PaCO 2 > 45 mmHg ) despite 60 minutes of optimal medical therapy
Clinical Signs : Criteria for Initiating NIV in AECOPD: Moderate-to-severe dyspnoea with tachypnoea ( RR > 25 breaths/min \text{RR} > 25\text{ breaths/min} RR > 25 breaths/min ), accessory muscle use, or abdominal paradox
Settings Protocol : Criteria for Initiating NIV in AECOPD: Inspiratory Positive Airway Pressure (IPAP) started at 10 − 12 cmH 2 O 10-12\text{ cmH}_2\text{O} 10 − 12 cmH 2 O ; Expiratory Positive Airway Pressure (EPAP) at 4 − 5 cmH 2 O 4-5\text{ cmH}_2\text{O} 4 − 5 cmH 2 O
Contraindications : Criteria for Initiating NIV in AECOPD: Cardiac or respiratory arrest, severe hemodynamic instability, facial burns/trauma, impaired consciousness/inability to protect airway, active vomiting, massive upper GI bleed
Primary references (checked 7 October 2026): Australian Asthma Handbook .